Versatile cationic lipids for siRNA delivery.
Jeff Sparks1, Gregory Slobodkin, Majed Matar
1EGEN Inc., 601 Genome Way, Huntsville AL 35806, USA. jsparks@egeninc.com
Summary
Researchers developed novel cationic lipopolyamines for safe and effective RNA interference (RNAi) therapy delivery. These nanoparticles successfully reduced target gene expression in lung tissue with minimal toxicity, showing promise for pulmonary disease treatments.
Area of Science:
- Biotechnology
- Molecular Biology
- Drug Delivery Systems
Background:
- RNA interference (RNAi) pathway holds therapeutic potential for various diseases.
- Current clinical development is hindered by the absence of safe and efficient delivery systems for RNAi-based drugs.
Purpose of the Study:
- To develop versatile cationic lipopolyamines for effective small interfering RNA (siRNA) delivery.
- To evaluate the in vivo efficacy and safety of modified lipopolyamines for pulmonary RNAi therapeutics.
Main Methods:
- Synthesized structurally versatile cationic lipopolyamines for siRNA delivery.
- Modified a core lipid (Staramine) with methoxypolyethylene glycols (mPEGs) for in vivo applications.
- Administered PEGylated Staramine nanoparticles with siRNA targeting caveolin-1 (Cav-1) transcript in vivo.
Main Results:
- Achieved high levels of target transcript knockdown in vitro across various cell types.
- Demonstrated significant reduction (up to 60%) of Cav-1 transcript in lung tissue 48 hours post-administration.
- Observed reduced toxicity associated with intravenous administration of mPEG-modified nanoparticles.
Conclusions:
- Developed lipopolyamines show potential as effective siRNA delivery vehicles.
- PEGylated Staramine nanoparticles are promising for RNAi therapeutics targeting pulmonary diseases.
- The system allows for tunable gene knockdown and reduced toxicity, facilitating clinical translation.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:30Small interfering RNAs (siRNA)
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...